European Archives - Page 1389 of 1449 - European Medical Journal

EMJ

Uninterrupted NOAC Therapy during AF Ablation Is Safe

Milan, Italy – 24 June 2015: Uninterrupted treatment with novel oral anticoagulants (NOACs) during catheter ablation of atrial fibrillation (AF) is safe…

EMJ

ESC Recommends Uninterrupted Vitamin K Antagonists during Ablation and Device Implantation

Milan, Italy – 23 June 2015: The European Society of Cardiology (ESC) has recommended uninterrupted anticoagulation with vitamin K antagonists…

EMJ

New Biomarkers Could Shine Beacon for Personalised Hepatitis C Therapy

BLOOD tests can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy. “While highly effective direct-acting…

EMJ

Starved T Cells Enable Undercover Liver Infection by Hepatitis B

HEPATITIS B has been shown to stimulate processes that deprive the body’s immune cells of key nutrients that they need to function. The findings explain…

EMJ

Patients Test Drive Pacemaker before Choosing Permanent Implant

Milan, Italy – 22 June 2015: Patients are test driving a pacemaker outside the skin before deciding whether to have a permanent implant…

EMJ

Cardiac Device Wearers Should Keep Distance from Smartphones

Milan, Italy – 22 June 2015: Cardiac device wearers should keep a safe distance from smartphones to avoid unwanted painful shocks or…

EMJ

New ICS Impulse Transforms Balance Assessment

Taastrup, Denmark | April, 2015 – GN Otometrics, the leading global manufacturer of hearing and balance instrumentation, announced today the…

Conquering C – Going Beyond Cure

Prof Zeuzem opened the symposium by acknowledging that there is a new era in hepatitis C virus (HCV) treatment, due to the availability of efficacious…

Answering Pivotal Questions in the Diagnosis and Treatment of Primary Biliary Cirrhosis and Non-Alcoholic Steatohepatitis

Professor Trauner introduced the subject of liver disease and its burden within the European Union (EU) and across the globe.

Would You Figure It Out? Differential Diagnoses: Beyond the Usual

The Synageva BioPharma-sponsored symposium discussed the differential diagnoses for liver diseases that may be under-recognised in clinical settings…